<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02533518</url>
  </required_header>
  <id_info>
    <org_study_id>1008041</org_study_id>
    <secondary_id>2010-A00343-36</secondary_id>
    <nct_id>NCT02533518</nct_id>
  </id_info>
  <brief_title>Ultra-Violet Fluorescence Bronchial Cancer Location</brief_title>
  <acronym>UVFBCL</acronym>
  <official_title>Ultra-Violet Fluorescence Bronchial Cancer Location</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnose lung cancer at an early stage is crucial for effective treatment. At these early
      stages, cancer is usually invisible in ambient white light when the endoscopic analysis of
      the bronchial mucosa. This lining is self-fluorescent at its illumination by blue light.
      These widely distributed autofluorescence methods detect early mucosal abnormalities. They
      are very sensitive but not specific to recognize the lung cancer. Thanks to European funding
      (EURIMUS), a new tool with fluorescent UV light has been developed.

      The purpose of this preliminary study is to verify the suitability for specific detection of
      cancerous tissue in Pneumology of this fluorescence method versus histological analysis of
      the tissue.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ultraviolet fluorescence ratio Iodine360 / Iodine450</measure>
    <time_frame>Day 0</time_frame>
    <description>Detection of cancerous tissues and healthy or inflammatory tissues is used to calculate the sensitivity and specificity of the rigid bronchoscopy with UV transmission compared to biopsy (gold standard).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histology of tissue</measure>
    <time_frame>Day 0</time_frame>
    <description>The histology give the final diagnosis</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>patients with lung cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rigid bronchoscopy with ultraviolet transmission</intervention_name>
    <arm_group_label>patients with lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <arm_group_label>patients with lung cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient affiliated or entitled to a social security scheme

          -  Major Patient

          -  Patient who signed the informed consent document

          -  Patient with a known primary cancer in bronchial level

        Exclusion Criteria:

          -  Pregnant woman

          -  Patient with a benign tumor histology

          -  Patient with an unknown tumor histology.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pneumology departement CHU Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2015</study_first_submitted>
  <study_first_submitted_qc>August 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2015</study_first_posted>
  <last_update_submitted>August 24, 2015</last_update_submitted>
  <last_update_submitted_qc>August 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Bronchogenic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

